Les publications HAL U991

2015

183 publication(s) :

Articles

: 21 -
: Incidence of brain metastases in HER2+ gastric or gastroesophageal junction adenocarcinoma.
: Christophe Blay, Dan Cristian Chiforeanu, Eveline Boucher, Florian Cabillic, Romain Desgrippes, Bérengère Leconte, Christophe Perrin, Sylvain Manfredi, B. Meunier, Julien Edeline
: Incidence of brain metastases in HER2+ gastric or gastroesophageal junction adenocarcinoma. Acta Oncologica, 2015, 54 (10), pp.1833-1835.
: DOI : https://doi.org/10.3109/0284186X.2015.1011757
: Pubmed : 25753188

: 22 -
: Suivi gynécologique des patientes atteintes d’un spina bifida
: D. Body-Bechou, A. -S. Cabaret-Dufour, L. Siproudhis, I. Berkelmans, A. Manunta, S. Odent, M. Jezequel, A. Prestel, P Poulain
: Gynécologie Obstétrique & Fertilité, 2015, 43 (7-8), pp.522-527.
: DOI : https://doi.org/10.1016/j.gyobfe.2015.05.002
: Pubmed : 26113168

: 23 -
: Association Between Handedness and Type 2 Diabetes: The E3N Study
: F Bonnet, Aurélie Affret, Marie-Christine Boutron-Ruault, Beverley Balkau, Françoise Clavel-Chapelon, Guy Fagherazzi
: Diabetes Care, 2015, 38 (12), pp.e199.
: DOI : https://doi.org/10.2337/dc15-1669
: Pubmed : 26486188

: 24 -
: Elevated heart rate predicts beta cell function in non-diabetic individuals: the RISC cohort
: Fabrice Bonnet, Jean-Philippe Empana, Andrea Natali, Lucilla Monti, Alain Golay, Katarina Lalic, Jacqueline Dekker, Andrea Mari, Beverley Balkau
: European Journal of Endocrinology, 2015, 173 (3), pp.409-15.
: DOI : https://doi.org/10.1530/EJE-15-0115
: Pubmed : 26034075

: 25 -
: Risque cardiovasculaire associé au diabète selon le sexe : pourquoi un excès de risque relatif chez les femmes diabétiques ?
: Fabrice Bonnet
: Médecine des Maladies Métaboliques, 2015, 9 (4), pp.371--376.
: DOI : https://doi.org/10.1016/S1957-2557(15)30137-1

: 26 -
: Change in Erythrocyte Mean Corpuscular Volume During Combination Therapy with Azathioprine and Infliximab Is Associated with Mucosal Healing: A Post hoc Analysis from SONIC.
: Guillaume Bouguen, Charles Sninsky, Kezhen L Tang, Jean-Frederic Colombel, Geert Dʼhaens, Asher Kornbluth, Gerassimos J Mantzaris, Daniel Rachmilewitz, Walter Reinisch, Paul Rutgeerts, Mark Molenda, C Jannekevan Der Woude, William J Sandborn
: Change in Erythrocyte Mean Corpuscular Volume During Combination Therapy with Azathioprine and Infliximab Is Associated with Mucosal Healing: A Post hoc Analysis from SONIC. Inflammatory Bowel Diseases, 2015, 21 (3), pp.606-14.
: DOI : https://doi.org/10.1097/MIB.0000000000000302
: Pubmed : 25581826

: 27 -
: Efficacy and Safety of Adalimumab 80 mg Weekly in Luminal Crohn's Disease.
: Guillaume Bouguen, David Laharie, Stéphane Nancey, Xavier Hebuterne, Bernard Flourie, Jérôme Filippi, Xavier Roblin, Caroline Trang, Arnaud Bourreille, Abdenour Babouri, Jean-François Bretagne, Laurent Siproudhis, Laurent Peyrin-Biroulet
: Efficacy and Safety of Adalimumab 80 mg Weekly in Luminal Crohn's Disease. Inflammatory Bowel Diseases, 2015, 21 (5), pp.1047-1053.
: DOI : https://doi.org/10.1097/MIB.0000000000000359
: Pubmed : 25803504

: 28 -
: Intestinal steroidogenesis
: Guillaume Bouguen, Laurent Dubuquoy, Pierre Desreumaux, Thomas Brunner, Benjamin Bertin
: Steroids, 2015, 103, pp.64-71.
: DOI : https://doi.org/10.1016/j.steroids.2014.12.022
: Pubmed : 25560486

: 29 -
: Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS).
: Marc Bourlière, Jean-Pierre Bronowicki, Victor de Ledinghen, Christophe Hézode, Fabien Zoulim, Philippe Mathurin, Albert Tran, Dominique G Larrey, Vlad Ratziu, Laurent Alric, Robert H Hyland, Deyuan Jiang, Brian Doehle, Phillip S Pang, William T Symonds, G Mani Subramanian, John G Mchutchison, Patrick Marcellin, François Habersetzer, Dominique Guyader, Jean-Didier Grangé, Véronique Loustaud-Ratti, Lawrence Serfaty, Sophie Metivier, Vincent Leroy, Armand Abergel, Stanislas Pol
: Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS). The Lancet Infectious Diseases, 2015, 15 (4), pp.397-404.
: DOI : https://doi.org/10.1016/S1473-3099(15)70050-2
: Pubmed : 25773757

: 30 -
: Anorectal dysfunction in patients with ulcerative colitis: impaired adaptation or enhanced perception?
: C. Brochard, L. Siproudhis, A. Ropert, A. Mallak, J.-F. Bretagne, G. Bouguen
: Neurogastroenterology & Motility, 2015, 27 (7), pp.1032-1037.
: DOI : https://doi.org/10.1111/nmo.12580
: Pubmed : 25940976